Maria Katapodi

Institution: University of Basel

Address:

Bernoullistrasse 28, 4056 Basel

Email: maria.katapodi@unibas.ch

Group website: www.swisscascade.ch

Phone: 079 109 5163

Research interests:

•Breast cancer prevention and control; family communication and support •Genetic counseling and testing of families at risk for hereditary cancer •Public health genomics •Perceived risk, cognitive function after chemotherapy treatment, and decision making for treatment and genetic testing; genetic variations related to attention and memory after treatment •Meta-analysis methodology Dr. Katapodi is interested in breast cancer prevention and decision-making about genetic testing and cancer screening. Her research is focused on women with pathogenic mutations that predispose them to breast and ovarian cancer (i.e., cognition, perceptions of risk, family communication, decisional conflict related to genetic testing, and cancer screening behaviors). During her tenure at the University of Michigan, US, Dr. Katapodi has tested the effects of a family-based communication and decision support intervention for families that harbor a cancer-predisposing mutation. She was also the PI of a multidisciplinary study testing the efficacy of two versions of an intervention (Targeted vs. Enhanced Tailored). The intervention was designed to increase screening in young breast cancer survivors (i.e., women whose age of diagnosis suggests hereditary/ familial breast cancer) and their high-risk female relatives. Dr. Katapodi has expertise in meta-analysis methodology. Her first meta-analysis examined the association between perceived breast cancer risk and screening behaviors. The second one examined the effects of interventions targeting family caregivers of cancer patients. Since moving to the University of Basel in 2014 Dr. Katapodi is working on establishing the Swiss Cancer Cascade Screening Consortium, a multidisciplinary consortium designed to promote informed decisions for genetic testing among families with cancer-predisposing mutations, and examine long-term effects of cancer susceptibility, such as long-term cancer surveillance, quality of life, family needs for communication, coping and support, caregiving burden. She is also examining long-term effects of chemotherapy on cognitive function.

Selected publications:

1. * Katapodi, MC, Duquette, D, Yang, JJ, Mendelsohn-Victor, KE, Anderson, B, Nikolaidis, C, Mancewicz, E. Northouse, LL, Duffy, S, Ronis, D†, Milliron, KJ, Probst-Herbst, N. Merajver, SD, Janz, NK, Copeland, G, Roberts, SJ. (Accepted). “Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.” Cancer Causes and Control (Accepted for publication on 24.01.2017). 2. *Jones, T, Lockhart, JS, Mendelsohn-Victor, K, Duquette, D, Northouse, LL, Duffy, S, Donley, R, Merajver, SD, Milliron, KJ, Roberts, JS, Katapodi, MC. (2016). “Use of cancer genetic services in African American young breast cancer survivors.” American Journal of Preventive Medicine, Apr 22. pii: S0749-3797(16)30074-5. doi: 10.1016/j.amepre.2016.03.016. [Epub ahead of print] 3.Freeman-Gibb, LA, Janz, NK, Katapodi, MC, Zikmund-Fisher, BJ, Northouse, LL (2016). “The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors.” Psycho-Oncology, DOI: 10.1002/pon.4143. [Epub ahead of print] 4.Kershaw, T, Ellis, KR, Yoon, H, Schafenacker, A, Katapodi, MC, Northouse, LL (2015) “The interdependence of advanced cancer patients’ and their family caregivers’ mental health, physical health, and self-efficacy over time.” Annals of Behavioral Medicine, Oct 21 Epub ahead of print DOI 10.1007/s12160-015-9743-y 5.Visvanathan, K, Hurley, P, Bantug, E, Brown, P, Col, N, Cuzick, J, Davidson, NE, De Censi, A, Fabian, C, Ford, L, Garber, J, Katapodi, MC, Kramer, B, Morrow, M, Parker, B, Runowicz, C, Vogel, V, Wade, JL, Lippman, SM. (2013). “Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline.” Journal of Clinical Oncology, 31(23):2942-2962. DOI: 10.1200/JCO.2013.49.3122. 6. Katapodi, MC, Northouse, LL, Schafenacker, AM, Duquette, D, Duffy, SA, Ronis, D, Anderson, B, Janz, N, McLosky, JM, Milliron, KJ, Merajver, SD, Duong, LM, Copeland. (2013). “Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: A protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.” BMC Cancer, 13(97). DOI: 10.1186/1471-2407-13-97. 7. Katapodi, MC, Northouse, LL, Milliron, KJ, Liu, G, Merajver, SD. (2013). “Individual and family characteristics associated with BRCA1/2 testing in high-risk families.” Psycho-Oncology, 22, 1336 – 1343. DOI: 10.1002/pon.3139. 8. Northouse LL, Katapodi MC, Song L, Zhang L, Mood DW. (2010). “Interventions with family caregivers of cancer patients: A meta-analysis of randomized trials.” CA: A Cancer Journal for Clinicians, 60(5), 317 – 339. DOI: 10.3322/caac.20081

Members List